(MWRD) Amundi MSCI World DR USD - Ratings and Ratios
Global Stocks, Large Cap Equity, Blend Funds
Description: MWRD Amundi MSCI World DR USD
The Amundi MSCI World UCITS ETF DR USD Acc GBP is an exchange-traded fund listed on XETRA, tracking the Morningstar Global TME NR USD index. As a Global Large-Cap Blend Equity ETF, it provides diversified exposure to a broad range of large-cap stocks across developed markets worldwide.
With Assets Under Management (AUM) of approximately £10.5 billion, this ETF is a sizable player in the global equity ETF market. Its size suggests sufficient liquidity and potentially lower trading costs for investors.
To evaluate the ETFs performance, we can consider key metrics such as tracking error, expense ratio, and dividend yield. Although not directly provided, we can infer that the ETFs tracking error is likely to be low given its adherence to a well-established index. The expense ratio, a crucial KPI for ETF investors, is not specified, but it is typically low for passive ETFs like this one, often below 0.2%. The dividend yield, another important metric, can be estimated based on the underlying indexs dividend profile.
From a technical analysis perspective, the ETFs price action indicates a relatively stable trend, with short-term and long-term moving averages (SMA20, SMA50, SMA200) suggesting a gradual uptrend. The Average True Range (ATR) of 0.72 (0.67%) implies moderate daily price volatility. Investors may use these technical indicators to inform their entry and exit strategies.
To further assess the ETFs attractiveness, we can examine its underlying index, the Morningstar Global TME NR USD. This index likely comprises a broad representation of global large-cap stocks, potentially offering a stable source of returns over the long term. Investors may also consider the ETFs currency exposure, as it is denominated in GBP but tracks a USD-based index, potentially introducing currency risk.
Additional Sources for MWRD ETF
MWRD ETF Overview
Market Cap in USD | 14,411m |
Category | Global Large-Cap Blend Equity |
IPO / Inception | 2024-01-18 |
MWRD ETF Ratings
Growth Rating | 38.0 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -7.46 |
Analysts | - |
Fair Price Momentum | 96.96 GBP |
Fair Price DCF | - |
MWRD Dividends
Currently no dividends paidMWRD Growth Ratios
Growth Correlation 3m | 89.2% |
Growth Correlation 12m | 35.7% |
Growth Correlation 5y | 72.8% |
CAGR 5y | 13.73% |
CAGR/Max DD 5y | 0.74 |
Sharpe Ratio 12m | 0.73 |
Alpha | -4.79 |
Beta | 0.719 |
Volatility | % |
Current Volume | 0k |
Average Volume 20d | 0k |
As of July 03, 2025, the stock is trading at GBP 107.83 with a total of 0 shares traded.
Over the past week, the price has changed by +1.08%, over one month by +3.01%, over three months by +4.45% and over the past year by +6.99%.
Partly, yes. Based on ValueRay´s Analyses, Amundi MSCI World DR USD (XETRA:MWRD) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 38.00 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MWRD is around 96.96 GBP . This means that MWRD is currently overvalued and has a potential downside of -10.08%.
Amundi MSCI World DR USD has no consensus analysts rating.
According to our own proprietary Forecast Model, MWRD Amundi MSCI World DR USD will be worth about 110.9 in July 2026. The stock is currently trading at 107.83. This means that the stock has a potential upside of +2.82%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 110.9 | 2.8% |